pone.0296775.g002.tif (152.3 kB)
Effect of CoQ10 on serum levels of LPPLA2, troponin, and creatinine kinase-MB.
figure
posted on 2024-01-16, 18:23 authored by Yousif Jameel Jbrael, Badraldin Kareem HamadAfter three weeks, serum levels of LPPLA2, cardiac troponin, and Creatinine kinase-MB were measured in three groups of experimental rats; the Normal control group (A) and the Diabetic control group (B), and the Diabetic group treated with CoQ10 (C). Serum levels of LPPLA2 were measured by enzyme-linked immunosorbent assay. Serum levels of cardiac troponin and creatinine kinase-MB were measured by UP—Converting Phosphor Immunoassay Analyzer. Data are presented as the mean ± SE (n = 7). Within the same duration of treatment, bars with different asterisks (*, **) differ from each other significantly (P < 0.05). Non-asterisk bars do not differ significantly from one another (P > 0.05) within the same duration of treatment.
History
Usage metrics
Categories
Keywords
conduct biochemical analysesaforementioned markers associatedprecipitating diabetic complicationspotential modulatory effectcardiac myopathy biomarkersnormal control grouphigher serum levelscoq10 per kilogramxlink "> twentysingle intraperitoneal injectionfour male ratshematological markers correlatedtreated diabetic groupcardiomyopathy markers improvedcoq10 significantly decreasedfasting blood glucosebasal diet supplementedxlink ">hematological markerscardiomyopathy markersfasting ratsdiabetic ratsdiabetic cardiomyopathycardiac enzymesblood glucosebeneficial effecthematological parametersserum samplesserum samplecoq10 mayw .)three weeksthree groupsthree dayssignificant increasesremain uninducedrandomly assignedph 4pancreatic betakg bhyperglycemic statushyperglycemic ratscoenzyme q10citrate bufferb ),ameliorating impact8 ).5 g5 ).45 mg21 days05 ).
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC